Loxapine
NDC Package 52152-192-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Loxapine is used to treat certain mental/mood disorders (such as schizophrenia). Marketed by Actavis Totowa Llc, this product is identified by NDC 52152-192 and is authorized under FDA application ANDA076868.

Identification & Billing

NDC Package Code
52152-192-05
Package Description
1000 CAPSULE in 1 BOTTLE
Product Code
52152-192
11-Digit Billing Format
52152019205

Clinical Specifications

Proprietary Name
Loxapine
Dosage Form
-
Usage Information
Loxapine is used to treat certain mental/mood disorders (such as schizophrenia). This medicine helps you to think more clearly, feel less nervous, and take part in everyday life. It can reduce aggression and the desire to hurt yourself/others. It may also help to decrease hallucinations (such as hearing/seeing things that are not there). Loxapine is a psychiatric medication (antipsychotic type) that works by helping to restore the balance of certain natural substances (such as dopamine) in the brain.

Regulatory & Marketing

Labeler Name
Actavis Totowa Llc
FDA Application #
ANDA076868
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-01-2006
End Marketing Date
08-20-2008
Listing Expiration
08-20-2008
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (52152-192). Click a package code to view its specific billing and regulatory data.

52152-192-02
100 CAPSULE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 52152-192-05 identifies a specific commercial package of 1000 capsule in 1 bottle of Loxapine, labeled by Actavis Totowa Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Actavis Totowa Llc on September 01, 2006. The current certification is valid through August 20, 2008.

What are the primary indications for this medication?

Loxapine is used to treat certain mental/mood disorders (such as schizophrenia). This medicine helps you to think more clearly, feel less nervous, and take part in everyday life. It can reduce aggression and the desire to hurt yourself/others. It may also help to decrease hallucinations (such as hearing/seeing things that are not there). Loxapine is a psychiatric medication (antipsychotic type) that works by helping to restore the balance of certain natural substances (such as dopamine) in the brain.

How is this Actavis Totowa Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 52152019205. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
52152-192-05
11-Digit CMS (5-4-2)
52152-0192-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.